Cite
HARVARD Citation
Anstadt, E. et al. (2022). Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy. Oncologist. pp. 799-808. [Online].